Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study by Ghobrial, Irene M, Dr, Weller, Edie, PhD, Vij, Ravi, MD, Munshi, Nikhil C, MD, Banwait, Ranjit, MS, Bagshaw, Meghan, BA, Schlossman, Robert, MD, Leduc, Renee, BS, Chuma, Stacey, RN, Kunsman, Janet, NP, Laubach, Jacob, MD, Jakubowiak, Andrzej J, MD, Maiso, Patricia, PhD, Roccaro, Aldo, MD, Armand, Philippe, MD, Dollard, Akari, BA, Warren, Diane, BS, Harris, Brianna, BS, Poon, Tiffany, BS, Sam, Amy, BA, Rodig, Scott, MD, Anderson, Kenneth C, Prof, Richardson, Paul G, MD

Get full text